2:44 PM
 | 
May 15, 2018
 |  BC Extra  |  Company News

Illumina to acquire Edico for $100M

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million.

SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate secondary analysis of...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >